Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer

Following initial standard chemotherapy (platinum/taxol), more than 75% of those patients with advanced stage epithelial ovarian cancer (EOC) experience a recurrence. There are currently no accurate prognostic tests that, at the time of the diagnosis/surgery, can identify those patients with advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikas, Jason B., Boylan, Kristin L.M., Skubitz, Amy P.N., Low, Walter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201114/
https://www.ncbi.nlm.nih.gov/pubmed/22084564
http://dx.doi.org/10.4137/CIN.S8104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201114/
https://www.ncbi.nlm.nih.gov/pubmed/22084564
http://dx.doi.org/10.4137/CIN.S8104

Ejemplares similares